This time we bring you an insightful interview with Frans Opdam, a medical oncologist and clinical pharmacologist at The Netherlands Cancer Institute (NKI). Frans is renowned for his active role within Cancer Core Europe, where he is the principal investigator in different initiatives such as the Basket of Baskets (BoB) trial and the CCE_DART project. Additionally, he leads the tumor working group phase 1 study.
Q1: Could you please explain about the Basket of Baskets (BoB) trial, what has been accomplished so far, and what are you working on?
Q2: Regarding CCE_DART, what can you tell us about the different Patient Reported Outcome (PRO) tools developed during the project and their significance?
Q3: From your perspective, where should the Clinical Trials and Translational Research pillar drive its efforts in the middle / long term?
